Gilman Hill Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Gilman Hill Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$214K	Buy	+1,125	New	+$193K	0.03%	224
2024 Q1	–	Sell	-1,625	Closed	-$221K	–	219
2023 Q4	$221K	Buy	+1,625	New	+$198K	0.04%	191
2023 Q3	–	Sell	-1,941	Closed	-$246K	–	213
2023 Q2	$246K	Buy	1,941 +316	+19%	+$41K	0.05%	183
2023 Q1	$210K	Hold	1,625	–	–	0.04%	191
2022 Q4	$213K	Buy	+1,625	New	+$210K	0.04%	202

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Gilman Hill Asset Management's IBB Position: Q2 2026 in Review

Gilman Hill Asset Management opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 1,125 shares worth $214K. The stake represents 0.03% of the portfolio and ranks #224 among its holdings. This is a return to the name: Gilman Hill Asset Management previously reported a position in IBB as recently as Q4 2023.

Gilman Hill Asset Management first reported a position in IBB in Q4 2022 and has held it in 5 quarters since. The position peaked at $246K in Q2 2023. 955 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Gilman Hill Asset Management held 1,125 shares of iShares Biotechnology ETF worth $214K as of Q2 2026.
iShares Biotechnology ETF was a new Gilman Hill Asset Management position in Q2 2026.
iShares Biotechnology ETF made up 0.03% of Gilman Hill Asset Management's portfolio in Q2 2026, its #224 holding.
Gilman Hill Asset Management first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 5 quarters since.
Gilman Hill Asset Management's iShares Biotechnology ETF position peaked at $246K in Q2 2023.
955 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Gilman Hill Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.